Literature DB >> 22427646

Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Jyotica Batra1, Jessica Robinson, Alexei S Soares, Alan P Fields, Derek C Radisky, Evette S Radisky.   

Abstract

Matrix metalloproteinase 10 (MMP-10, stromelysin-2) is a secreted metalloproteinase with functions in skeletal development, wound healing, and vascular remodeling; its overexpression is also implicated in lung tumorigenesis and tumor progression. To understand the regulation of MMP-10 by tissue inhibitors of metalloproteinases (TIMPs), we have assessed equilibrium inhibition constants (K(i)) of putative physiological inhibitors TIMP-1 and TIMP-2 for the active catalytic domain of human MMP-10 (MMP-10cd) using multiple kinetic approaches. We find that TIMP-1 inhibits the MMP-10cd with a K(i) of 1.1 × 10(-9) M; this interaction is 10-fold weaker than the inhibition of the similar MMP-3 (stromelysin-1) catalytic domain (MMP-3cd) by TIMP-1. TIMP-2 inhibits the MMP-10cd with a K(i) of 5.8 × 10(-9) M, which is again 10-fold weaker than the inhibition of MMP-3cd by this inhibitor (K(i) = 5.5 × 10(-10) M). We solved the x-ray crystal structure of TIMP-1 bound to the MMP-10cd at 1.9 Å resolution; the structure was solved by molecular replacement and refined with an R-factor of 0.215 (R(free) = 0.266). Comparing our structure of MMP-10cd·TIMP-1 with the previously solved structure of MMP-3cd·TIMP-1 (Protein Data Bank entry 1UEA), we see substantial differences at the binding interface that provide insight into the differential binding of stromelysin family members to TIMP-1. This structural information may ultimately assist in the design of more selective TIMP-based inhibitors tailored for specificity toward individual members of the stromelysin family, with potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427646      PMCID: PMC3346077          DOI: 10.1074/jbc.M112.341156

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  85 in total

Review 1.  Electrostatic aspects of protein-protein interactions.

Authors:  F B Sheinerman; R Norel; B Honig
Journal:  Curr Opin Struct Biol       Date:  2000-04       Impact factor: 6.809

2.  ARP/wARP and molecular replacement.

Authors:  A Perrakis; M Harkiolaki; K S Wilson; V S Lamzin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-09-21

3.  Automated protein model building combined with iterative structure refinement.

Authors:  A Perrakis; R Morris; V S Lamzin
Journal:  Nat Struct Biol       Date:  1999-05

Review 4.  Tissue inhibitors of metalloproteinases: evolution, structure and function.

Authors:  K Brew; D Dinakarpandian; H Nagase
Journal:  Biochim Biophys Acta       Date:  2000-03-07

5.  NMR structure of tissue inhibitor of metalloproteinases-1 implicates localized induced fit in recognition of matrix metalloproteinases.

Authors:  B Wu; S Arumugam; G Gao; G I Lee; V Semenchenko; W Huang; K Brew; S R Van Doren
Journal:  J Mol Biol       Date:  2000-01-14       Impact factor: 5.469

6.  Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.

Authors:  Q Meng; V Malinovskii; W Huang; Y Hu; L Chung; H Nagase; W Bode; K Maskos; K Brew
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

7.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

Authors:  M D Winn; M N Isupov; G N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-01

8.  Tyrosine 36 plays a critical role in the interaction of the AB loop of tissue inhibitor of metalloproteinases-2 with matrix metalloproteinase-14.

Authors:  R A Williamson; M Hutton; G Vogt; M Rapti; V Knäuper; M D Carr; G Murphy
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

9.  The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations.

Authors:  G S Butler; M Hutton; B A Wattam; R A Williamson; V Knäuper; F Willenbrock; G Murphy
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

Review 10.  Matrix metalloproteinase inhibitors and cancer: trials and tribulations.

Authors:  Lisa M Coussens; Barbara Fingleton; Lynn M Matrisian
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

View more
  46 in total

1.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

Review 2.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 3.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 4.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

6.  Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Kerrie A Greene; Banumathi Sankaran; Gregory P Downey; Derek C Radisky; Evette S Radisky
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

Review 7.  Biochemical and Biological Attributes of Matrix Metalloproteinases.

Authors:  Ning Cui; Min Hu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-22       Impact factor: 3.622

Review 8.  Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.

Authors:  Yunfei Chen; Wei Peng; Joseph D Raffetto; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-03-21       Impact factor: 3.622

Review 9.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

10.  Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.

Authors:  Haiyin Zou; Ying Wu; Keith Brew
Journal:  J Biol Chem       Date:  2016-03-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.